FIELD: chemistry.
SUBSTANCE: invention describes novel 18-methyl-19-norandrost-4-ene 17,17-spiroethers of general formula 1 in which Z denotes an oxygen atom, R4 denotes a hydrogen atom, a chlorine atom, R6 and/or R7 can have an α or β configuration, and R6 and R7 independently denote a hydrogen atom or straight or branched alkyl group containing 1-4 or 3-4 carbon atoms, or a straight or branched alkenyl group containing 2-4 or 3-4 carbon atoms, or a saturated cycloalkyl group containing 3-5 carbon atoms, or together denote a methylene group or a double bond.
EFFECT: novel compounds have progestational activity and antimineralocorticoid activity.
2 cl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS | 2008 |
|
RU2466137C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
15β-SUBSTITUTED STEROIDS WITH SELECTIVE OESTROGENIC ACTIVITY | 2005 |
|
RU2386637C2 |
DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
3-METHYLENE-STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 2000 |
|
RU2248358C2 |
DROSPYRENON FOR REPLACEMENT HORMONOTHERAPY | 2001 |
|
RU2275198C2 |
17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
17 β -OXYESTRATRIENES | 2002 |
|
RU2339643C2 |
19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
DERIVATIVES OF 19-NORPREGNENE, PHARMACEUTICAL COMPOSITION, COMPOUNDS | 1997 |
|
RU2166509C2 |
Authors
Dates
2012-01-20—Published
2007-06-29—Filed